The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

To the Editor: Partial complex temporal epilepsy of adolescents and young adults is frequently due to hippocampal sclerosis. Partial complex temporal seizures are characterized by sudden onset and transient disorders of consciousness. In addition to disorders of consciousness, motor stereotypies, hallucinations (olfactory, gustatory, somatosensory, and auditory), delusions, and cognitive and affective signs can also be observed, making temporal lobe epilepsy one of the differential diagnoses of psychosis. However, temporal lobe epilepsy and psychosis are often comorbid conditions.1

The neurosurgical treatment of epilepsy was developed in 1950 by Penfield, in Montreal, and then by Talairach and Bancaud, in Paris.2 Amygdalohippocampectomy is performed in selected patients with refractory epilepsy.3 The post-surgical results are generally very satisfactory in terms of seizure control, allowing discontinuation of pharmacotherapy in one-third of cases.4 However, emotional disturbances, such as affective blunting,5 may occur and are usually attributed to resection of limbic structures.

The clinical impact of a surgical lesion of the limbic system is based on the concept of “neurological athymhormia,” considered to be a specific impairment of motivation in humans6 (the general concept of “limbic system” is used to designate the more restrictive brain damage of basal ganglia).

The characteristic diagnostic triad of neurological athymhormic syndrome includes variable combinations of disorders of affect, motor skills, and motivation.7,8 Intellectual functions are preserved. In the athymhormy of adult brain injury, the nature of emotional feeling is intact, but expression of emotions is lacking, leading to “loss of self-activation.”7 We describe the case of “Mr L.,” who presented a specific loss of emotional sensitivity; an emotional distress that does not correspond to that classically described in the literature in patients operated on for refractory epilepsy.

Case Report

The patient developed febrile convulsions at the age of 2 years. After the death of his father (when he was 7), the young child developed behavioral changes that required placement in foster care until the age of 16. This antisocial behavior required prolonged antipsychotic treatment. He also experienced auditory hallucinations at the age of 13, but these productive symptoms were poorly defined and are not suggestive of preexisting psychotic illness. At the age of 22, he developed a first episode of delirium with wandering lasting about 45 minutes. A second episode occurred several days later and was associated with signs indicative of complex partial seizure, as it was associated with olfactory hallucinations, unresponsiveness with fixed gaze, and chewing movements for 2 minutes. Seizures persisted at a rate of 3–4/day; despite being given valproate (3 g/day), a secondary generalized seizure occurred, and gabapentin (2.4 g/day) was added. As seizures persisted, valproate (2 g/d) was added, in combination with vigabatrin (3 g/d) in 1996 and carbamazepine (600 mg/d) in 1996. Video EEG indicated a left temporal focus, and MRI showed left hippocampal sclerosis. At the age of 31, Mr L. underwent left amygdalohippocampectomy for the treatment of refractory temporal epilepsy (Figure 1). After surgery, seizures were controlled without antiepileptic drugs. When he was referred for psychiatric examination, he reported a change of his emotional state: Mr. L appeared to be indifferent to the world around him and observed his emotional inertia. According to the patient, he felt that his reason was disconnected from emotional processes. The patient’s mother and doctor described marginalization since surgery: although he was able to maintain his sedentary job, he repeatedly requested a transfer. At the time of the assessment, he had no fixed address and no motor vehicle. He presented a fixed and durable mode of functioning. Mr L. described experiencing a “high” state since 2003, for which he was not responsible. Although his speech has become strange since the operation, he did not present any definite delusional features.

FIGURE 1. Brain MRI Axial Plane T2-Weighted Sequence

Arrows indicate signal change in the left temporo-polar (top left image), hippocampus-amygdala (lower image), and lateral temporal (top right image) regions.

Complaining of having “lost all emotional feeling,” Mr. L consulted a psychiatrist in 2009, 6 years after surgery. This consultation provided a comprehensive review. Laboratory tests did not show any abnormality. Neuropsychological assessment of this right-handed patient with secondary school education was performed in the Amiens Memory Clinic. It showed normal general cognitive abilities (Table 1), word-finding difficulties while other language modalities (repetition, comprehension, reading, writing) (Godefroy et al., 2003) were spared, and preservation of visual identification and visuoconstructive abilities. Episodic memory for verbal material was impaired, with a profile (preservation of immediate recall, impairment of recognition and recall without normalization following cueing) suggesting a genuine memory deficit related to a mediotemporal lesion (Godefroy et al., 2008). Executive functions were normal for both cognitive (i.e., tests) and behavioral components. Assessment of socio-emotional cognition was impaired, with impaired recognition of facial emotion (prominent for fear, disgust, and neutral emotions), empathy, and identification of inappropriate social behavior.

TABLE 1. Neuropsychological Performance
DomainsTestsPerformance
General cognitive abilitiesMini-Mental State Exam (Folstein et al., 1975)28/30
Progressive Matrix 47 (Raven, 1965)35/36
Mattis Dementia Rating Scale (Mattis, 1976)140/144
LanguageBDAE score (Goodglass and Kaplan, 1983)5/5
Confrontation naming (Deloche and Hannequin, 1989)76*/80
Verbal fluency (Godefroy et al., 2010)8
Animals15*
Letter P16
Shortened Token test (De Renzi and Faglioni, 1978)32/36
Visual and visuoconstructive abilitiesCancellation test (Albert, 1973)0 omission
Rey complex figure copy (Rey, 1959)34/36
Identification (Agniel et al., 1994)
Identical figures10/10
Overlapping figures33/36
Functional matching10/10
Categorical matching9/10
Short-term memory, Episodic memory: visual material, verbal materialDigit span: forward /backward (Wechsler, 1955)5/4
Doors test (Baddeley et al., 1994)19/24
Complex figure memory (Rey, 1959)23/36
Selective Reminding test (Grober and Buschke, 1987)
Immediate recall14/16
Free-recall total14*/48
Total recall total32*/48
Recognition14*/16
Executive functions8Trail-Making test, part A: time (sec)/error24/0 error
part B: time (sec)/error100/2*
Stroop Interference index2
Dual task (mu)85
Brixton: error15
Modified Card-Sorting: category/perseveration6/1
Behavioral Dysexecutive Syndrome Inventory: impaired domains0/12
Empathy and socio-emotional cognitionRecognition of facial emotion947*/60
Faux Pas test106*/10
Interpersonal Reactivity Index1155*/112

* performance impaired at the 5% level.

TABLE 1. Neuropsychological Performance
Enlarge table

No preoperative psychiatric assessment was available for Mr L., but his preoperative history suggested that these subjective changes were “de novo.” However, the emotional “void” that he has experienced since surgery in 2003 does not correspond to any of the neurocognitive, psychosocial, and psychiatric complications described in the literature.5,912

Discussion

The patient’s family reported a “change of lifestyle” that occurred after neurosurgery. Eight years after the operation, Mr L.’s capacity to feel and express his emotions was significantly altered, but neither the investigations nor a detailed review of the complications described in the literature were able to provide a satisfactory diagnosis for his disorders (especially as there is no classification, at the present time, adapted to the description of neuropsychiatric symptoms20).

There has been a growing interest in the psychiatric outcomes of patients undergoing epilepsy surgery in view of the high prevalence of presurgical psychiatric disorders and the potentially negative impact of surgery.2,21 More than one-half of surgical patients with presurgical psychiatric disorders experience remission of symptoms after surgery.2,21 According to Filho et al.,21 “de novo” psychiatric disorders are detected in 9.6% of patients. In the same study, the presence of presurgical depression, presurgical interictal psychosis, and epileptiform discharges contralateral to the epileptogenic zone were risk factors associated with post-surgical psychiatric disorders. On the other hand, seizure freedom and improved psychosocial status predict remission of preoperative psychopathology.22 However, Mr L. developed de-novo symptoms despite control of seizures.

How can the emotional changes experienced by this patient be described? Can a detailed analysis of his symptoms provide an answer?

Tamminga et al., in 1992, suggested involvement of the limbic system in the pathophysiology of schizophrenia.23 In a study published in 1999, Evangeli et al. established a correlation between the emotional disorders of schizophrenia and those related to a lesion of the amygdala.24 These findings were confirmed by Fahim et al. in 2005, who proposed the hypothesis of a disorder of the connection between the amygdala and the frontal cortex to explain the emotional disorders observed in schizophrenia.25 It therefore appears to be fairly well established that the brain of schizophrenia patients presents structural anomalies, mainly affecting the amygdala and hippocampus, the key structures of the limbic system.

Moreover, disorders of affectivity constitute the core deficit of schizophrenic illness and are formulated into several clinical concepts, as explained below. The gap between the expression, experience, and perception of feelings of schizophrenia patients was described as an “emotional paradox”26 by Aleman and Kahn in 2005. Dulling of emotion (or reduction of emotional expression) resulting from of this “emotional paradox” is a key symptom of schizophrenia. Anhedonia, the neologism proposed by Ribot in 1896 to describe loss of sensitivity to pleasure,27 can be considered to be a characteristic symptom of schizophrenia, at the border between emotional and mood disorders. Finally, the term ”psychiatric athymhormy,” which refers to weakening of the vital impulse and emotions, is used in psychiatry to characterize the psychopathological deficit of hebephrenia.28

However, the concept of anhedonia appears to be insufficient and inadequate to account for the emotional and affective “void” experienced by Mr. L. since the operation. The diagnosis of schizophrenia, according to the current definition of DSM-IV-TR,29 cannot be proposed, but resection of the left cerebral amygdala would appear to be responsible for the patient’s symptoms.

As the neuropsychiatric concepts of anhedonia, psychiatric and neurological athymhormic syndrome, and dulling of emotions fail to describe our patient’s emotional state, we propose the term emotional stoicism, by making an epistemological leap from neurological medicine to philosophy, as envisaged by Damasio.30

Mr. L. presented emotional impassiveness and serenity that resemble the descriptions proposed by the Stoic philosophers. This impassiveness and serenity also result from emotional insensitivity, acquired and directly related to the surgery performed in 2003. As amygdalohippocampectomy performed for the treatment of resistant epilepsy involves resection of the cerebral amygdala, we assume that emotional stoicism is a specific complication of this surgery. We propose the following diagnostic triad for emotional stoicism: the patient must have undergone amygdalohippocampectomy; must present clinical loss of emotional sensitivity (“apathy”); and must derive pleasure from his state of impassiveness (serenity).

By assuming that amygdalohippocampectomy induced a state of acquired emotional insensitivity (via disconnection of fronto-insular networks, actively involved in social-emotional disorders?), the case of Mr. L. resembles the emotional after-effects of lobotomy, performed until the middle of the 20th century for the treatment of schizophrenia and consisting of interruption of fronto-limbic nerve fibers.31 Braslow described a marked reduction of emotional spontaneity: “it is as if he had lost his soul.”32 Today, surgeons performing functional neurosurgery seek “to reduce the emotional experience of the symptoms.”33 Lesions of the limbic system and emotional after-effects are strictly linked (anecdotally, but corresponding to anatomical-clinical correlations, Maguire et al., in 2000, showed that the volume of the hippocampus, a structure involved in spatial memory and navigation, is increased among taxi drivers, as compared with the general population34).

Mr. L. received oral information from the neurosurgeon that specifically concerned the risk of neurocognitive after-effects. However, the information delivered to candidates for amygdalohippocampectomy should probably include the risk of loss of emotional sensitivity (although this complication is exceptional35) and its psychosocial consequences. Preparation of a standard document designed to inform patients would facilitate standardized collection of informed-consent in neurosurgery. Finally, further studies are required to clarify the emotional status of post-surgery epileptic patients, and the clinical cases of patients treated by amygdalohippocampectomy could be considered in the light of this new approach.

Emergency Dept. Philippe Pinel Hospital Amiens, France
Correspondence: Dr. Hequette; e-mail:
References

1 Filho GM, Rosa VP, Lin K, et al.: Psychiatric comorbidity in epilepsy: a study comparing patients with mesial temporal sclerosis and juvenile myoclonic epilepsy. Epilepsy Behav 2008; 13:196–201Crossref, MedlineGoogle Scholar

2 Talairach J, Bancaud J, Szikla G: Approche nouvelle de la neurochirurgie de l’épilepsie. Méthodologie stéréotaxique et résultats thérapeutiques. Neurochirurgie 1974; 20:204–205Google Scholar

3 Agence Nationale d’Accréditation et d’Evaluation en Santé: Prise en charge des épilepsies partielles pharmaco-résistantes. Paris, ANAES, 2004Google Scholar

4 Noachtar S, Borggraefe I: Epilepsy surgery: a critical review. Epilepsy Behav 2009; 15:66–72Crossref, MedlineGoogle Scholar

5 Devinsky O, Barr WB, Vickrey BG, et al.: Changes in depression and anxiety after resective surgery for epilepsy. Neurology 2005; 65:1744–1749Crossref, MedlineGoogle Scholar

6 Habib M: Neurologie de l’action et de la motivation: de l’athymhormie à l’hyperactivité. Encephale 2006; 32:10–24CrossrefGoogle Scholar

7 Laplane D, Dubois B: Les troubles affectifs de la perte d’auto-activation psychique: comparaison avec ceux de l’athymhormie. Rev Neurol (Paris) 1998; 154:35–39MedlineGoogle Scholar

8 Godefroy O, Azouvi P, Robert P, et al.: Groupe de Réflexion sur l’Evaluation des Fonctions Exécutives Study Group: Dysexecutive syndrome: diagnostic criteria and validation study. Ann Neurol 2010; 68:855–864Crossref, MedlineGoogle Scholar

9 Narme P, Mouras H, Loas G, et al.: Vers une approche neuropsychologique de l’empathie. Rev Neuropsychol (Marseille) 2010; 2:292–298CrossrefGoogle Scholar

10 Stone VE, Baron-Cohen S, Knight RT: Frontal lobe contributions to theory of mind. J Cogn Neurosci 1998; 10:640–656Crossref, MedlineGoogle Scholar

11 Davis MH: Measuring individual differences in empathy: evidence for a multidimensional approach. J Pers Soc Psychol 1983; 44:113–126CrossrefGoogle Scholar

12 Wilson SJ, Bladin P, Saling M: The “burden of normality:” concepts of adjustment after surgery for seizures. J Neurol Neurosurg Psychiatry 2001; 70:649–656Crossref, MedlineGoogle Scholar

13 Hill D, Pond DA, Mitchell W, et al.: Personality changes following temporal lobectomy for epilepsy. J Ment Sci 1957; 103:18–27Crossref, MedlineGoogle Scholar

14 Carran MA, Kohler CG, O’Connor MJ, et al.: Mania following temporal lobectomy. Neurology 2003; 61:770–774Crossref, MedlineGoogle Scholar

15 Anhoury S, Brown RJ, Krishnamoorthy ES, et al.: Psychiatric outcome after temporal lobectomy: a predictive study. Epilepsia 2000; 41:1608–1615Crossref, MedlineGoogle Scholar

16 Kulaksizoglu IB, Bebek N, Baykan B, et al.: Obsessive-compulsive disorder after epilepsy surgery. Epilepsy Behav 2004; 5:113–118Crossref, MedlineGoogle Scholar

17 Ney GC, Barr WB, Napolitano C, et al.: New-onset psychogenic seizures after surgery for epilepsy. Arch Neurol 1998; 55:726–730Crossref, MedlineGoogle Scholar

18 Shaw P, Mellers J, Henderson M, et al.: Schizophrenia-like psychosis arising de novo following a temporal lobectomy: timing and risk factors. J Neurol Neurosurg Psychiatry 2004; 75:1003–1008Crossref, MedlineGoogle Scholar

19 Stone VE, Baron-Cohen S, Calder A, et al.: Acquired theory of mind impairments in individuals with bilateral amygdala lesions. Neuropsychologia 2003; 41:209–220Crossref, MedlineGoogle Scholar

20 Krishnamoorthy ES, Trimble MR, Blumer D: The classification of neuropsychiatric disorders in epilepsy: a proposal by the ILAE Commission on Psychobiology of Epilepsy. Epilepsy Behav 2007; 10:349–353Crossref, MedlineGoogle Scholar

21 Filho GM, Mazetto L, Gomes FL, et al.: Pre-surgical predictors for psychiatric disorders following epilepsy surgery in patients with refractory temporal lobe epilepsy and mesial temporal sclerosis. Epilepsy Res 2012; 102:86–93; available at doi: 10.1016/j.epilepsyres.2012.05.005Crossref, MedlineGoogle Scholar

22 Hellwig S, Mamalis P, Feige B, et al.: Psychiatric comorbidity in patients with pharmaco-resistant focal epilepsy and psychiatric outcome after epilepsy surgery. Epilepsy Behav 2012; 23:272–279Crossref, MedlineGoogle Scholar

23 Tamminga CA, Thaker GK, Buchanan R, et al.: Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry 1992; 49:522–530Crossref, MedlineGoogle Scholar

24 Evangeli M, et al.: Face processing in schizophrenia: parallels with the effects of amygdala damage. Cogn Neuropsychiatry 1999; 4:1–24Crossref, MedlineGoogle Scholar

25 Fhim C, Stip E, Mancini-Marïe A, et al.: Brain activity during emotionally negative pictures in schizophrenia with and without flat affect: an fMRI study. Psychiatry Res 2005; 140:1–15Crossref, MedlineGoogle Scholar

26 Aleman A, Kahn RS: Strange feelings: do amygdala abnormalities dysregulate the emotional brain in schizophrenia? Prog Neurobiol 2005; 77:283–298MedlineGoogle Scholar

27 Loas G: L’anhédonie: l’insensibilité au plaisir. Doin, 2002Google Scholar

28 Dide M, Guiraud P: Psychiatrie du médecin praticien, 1ère Edition. Paris, Masson, 1922Google Scholar

29 American Psychiatric Association: DSM-IV-TR. Manuel Diagnostique et Statistique des Troubles Mentaux, 4ème Edition, Texte Révisé. Washington, DC, 2000Google Scholar

30 Damasio A: L’Erreur de Descartes: La Raison des Émotions. Paris, Odile Jacob, 1995Google Scholar

31 Freeman WJ, Watts WJ: Psychosurgery in the Treatment of Mental Disorders and Intractable Pain. Springfield, IL,1950, p 406Google Scholar

32 Braslow J: Mental Ills and Bodily Cures: Psychiatric Treatment in the First Half of the Twentieth Century. Berkeley, CA, University of California Press, 1997Google Scholar

33 Comité Consultatif National d’Ethique Pour les Sciences de la Vie et de la Santé: La neurochirurgie fonctionnelle d’affections psychiatriques sévères. Avis n°71; 25 avril, 2002Google Scholar

34 Maguire EA, Gadian DG, Johnsrude IS, et al.: Navigation-related structural change in the hippocampi of taxi drivers. Proc Natl Acad Sci U S A 2000; 97:4398–4403Crossref, MedlineGoogle Scholar

35 Ordre National des Médecins. Information du patient dans la loi du 4 mars 2002. Accès aux informations de santé. France; 18 août 2003 (mis à jour en octobre 2005); p 3Google Scholar